BioGene Therapeutics names Dr. Francis Tavares as CTO

Go back to BioGene Therapeutics names Dr. Francis Tavares as CTO
(AMEX: PRVCF) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High
Open $0.01    52 Week Low
Day High $0.01    P/E N/A 
Day Low $0.01    EPS
Volume 50,000